Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys

NCT05714514 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation in Highly Sensitized Patients

Interventions

DRUG: Imlifidase administered in the ConfIdeS study
OTHER: Best available treatment administered in the ConfIdeS study

Sponsor

Hansa Biopharma AB